Identification of compositions, compositions, and methods of treatment of obesity and overweight conditions
View Patent ↗A method for the identification of a composition useful in the treatment of an overweight or obese person to reduce the person's body mass index is provided which comprises obtaining an extract of an ethnobotanical plant, and evaluating the activity of the extract in an assay selected from the group consisting of a lipolysis assay, an assay that measures the amount of glycerol introduced by a cell into a suspension medium of the cell, an adipocyte differentiation assay, an assay that measures the level of the enzyme glycerol-3-phosphate dehydrogenase, an assay that measures the inhibition of differentiation of preadipocytes to adipocytes, an assay that measures the accumulation of lipid in an adipocyte, an assay that measures the de-differentiation of adipocytes into preadipocytes, and combinations thereof. Sclareol and sclareol-like compounds and sclareolide and sclareolide-like compounds are identified as useful in the treatment of overweight and obese conditions and disorders and conditions associated with adipose tissue abnormalities. These compounds can be formulated for oral administration.
1. A method of treatment of obesity in a patient with a body mass index of 30 kg/m 2 or greater, comprising administering a therapeutically effective amount of at least one of sclareol and sclareolide to the patient to reduce said body mass index.
2. The method of treatment as in claim 1 , comprising administering to the patient of at least one of a compound of sclareol and sclareolide in an amount effective to reduce the body mass index of the patient from a value greater than 30 kg/m 2 to a value of 30 kg/m 2 or less.
3. The method of treatment as in claim 1 , wherein said at least one of a compound of sclareol and sclareolide is substituted with one of alkalyl, aryl, halogen, hydroxyl and amino groups.
4. The method of treatment as in claim 1 , wherein said at least one of a compound of sclareol and sclareolide comprises at least one of an optical isomer, chiral compound and a mixture of optical isomer and chiral compound thereof.
5. The method of treatment as in claim 1 , further comprising administering said compound as an amount effective to at least one of induce lipolysis and increase leptin secretion.
6. The method of treatment of claim 1 , wherein said compounds are obtained as an extract of a plant.
7. The method of claim 1 , further comprising administering said compound in oral form.